Sophia Genetics SA
SOPH
$4.85
Closing
▼-2.61%
1D
▲2.97%
YTD
Market cap
$316.71M
52 week high
$7.37
52 week low
$2.18
Volume
72,301
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Market cap
$316.71M
Analysts' Rating
BUY
Price Target (Mean)
8.33333
Total Analysts
3
P/E
Operating Margin
-101.48%
Beta
Revenue Growth (Annual)
17.58%
52 week high
$7.37
52 week low
$2.18
Div. Yield
%
EPS Annual Growth
-36.36
Note on Purification and Zakat
- Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly).
- If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
- For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them.
Company Profile
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform – the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.
